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Objective: In patients with knee OA, synovitis is associated with knee pain and symptoms. We previously
identiﬁed synovial mRNA expression of a set of chemokines (CCL19, IL-8, CCL5, XCL-1, CCR7) associated
with synovitis in patients with meniscal tears but without radiographic OA. CCL19 and CCR7 were also
associated with knee symptoms. This study sought to validate expression of these chemokines and as-
sociation with knee symptoms in more typical patients presenting for meniscal arthroscopy, many who
have pre-existing OA.
Design: Synovial ﬂuid (SF) and biopsies were collected from patients undergoing meniscal arthroscopy.
Synovial mRNA expression was measured using quantitative RT-PCR. The Knee Injury and Osteoarthritis
Outcome Score (KOOS) was administered preoperatively. Regression analyses determined if associations
between chemokine mRNA levels and KOOS scores were independent of other factors including radio-
graphic OA. CCL19 in SF was measured by ELISA, and compared to patients with advanced knee OA and
asymptomatic organ donors.
Results: 90% of patients had intra-operative evidence of early cartilage degeneration. CCL19, IL-8, CCL5,
XCL1, CCR7 transcripts were detected in all patients. Synovial CCL19 mRNA levels independently
correlated with KOOS Activities of Daily Living (ADL) scores (95% CI [8.071, 0.331], P ¼ 0.036), indi-
cating higher expression was associated with more knee-related dysfunction. SF CCL19 was detected in 7
of 10 patients, compared to 4 of 10 asymptomatic donors.
Conclusion: In typical patients presenting for meniscal arthroscopy, synovial CCL19 mRNA expression
was associated with knee-related difﬁculty with ADL, independent of other factors including presence of
radiographic knee OA.
© 2015 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Osteoarthritis (OA) is a common joint disease characterized by
degeneration of cartilage and other joint structures and remodeling
of subchondral bone. The knee is the most common joint affected: C.R. Scanzello, Division of
n School of Medicine, 3400
4, PA, USA. Tel: 1-215-823-
).
ternational. Published by Elsevier Lby OA. Joint injuries such as meniscal tears are a strong risk factor
for both incidence and progression of knee OA1,2. The Multicenter
OA Study (MOST), a longitudinal study of the natural history of OA
progression, demonstrated that meniscal damage is associated
with a 6-fold increased risk of developing radiographic changes of
OA3. Although meniscal damage in patients with knee OA is clearly
associated with disease progression, it is not clear whether
meniscal damage is always associated with knee pain or joint
dysfunction3e5. In addition, population based studies have shown
that there is a discordance between radiographic ﬁndings of
structural joint changes and knee symptoms in patients with OA6,7.td. All rights reserved.
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variable characteristic of disease but is potentially involved in the
arthritic process. A number of studies have shown that synovial
inﬂammation (synovitis) is associated with both risk of progression
of cartilage loss8,9 and knee pain10,11. There is a need for a greater
understanding of the role of synovitis in patients with meniscal
tears and OA, and for the development of better biomarkers of
synovitis to identify patients at risk for development and progres-
sion of symptomatic OA. We recently reported an association be-
tween synovitis and preoperative knee symptoms12 in patients
undergoing arthroscopic partial meniscectomy with a history of
traumatic knee injury but no radiographic evidence of OA. Synovitis
was already present in 40% of these patients and was associated
with worse preoperative pain and function measured using the
Lysholm score13. Microarray analysis of synovial gene expression
patterns identiﬁed a set of chemokines (IL-8, CCL5, XCL1, and CCL19
and its receptor CCR7) associated with the presence of synovitis.
Expression levels of CCL19 and its receptor CCR7 were also asso-
ciated with worse Lysholm scores, suggesting these inﬂammatory
mediators may be useful in identifying patients with a detectable
synovial inﬂammatory response after meniscal injury. Our ﬁndings
using both histologic analysis and mRNA analysis of synovial in-
ﬂammatory markers established a relationship between synovitis
and worse symptoms in these meniscal injury patients who are at
risk for development of OA.
Many patients referred for arthroscopic meniscal surgeries
already have evidence of early radiographic OA, and don't always
have a clear history of joint injury5. Therefore it was not clear
whether ﬁndings from our previous study could be generalized to
typical patients with meniscal damage undergoing arthroscopic
procedures, or whether the relationship between inﬂammatory
chemokines and symptoms would be independent of pre-existing
OA. Our current study was designed to validate the relationship
between synovial chemokine expression and knee symptoms in
more representative patients, in order to determine whether the
inﬂammatory chemokines identiﬁed previously might have utility
as markers of inﬂammation in a more typical clinical population.Materials and methods
Patients and tissue collection
Biospecimens (synovial tissues and ﬂuids) for these in-
vestigations were obtained from three different tissue repositories
maintained at Rush University Medical Center: Specimens from
patients with meniscal tears were obtained from the Knee Injury
and Arthritis repository; specimens from advanced knee OA pa-
tients were obtained from the Orthopedic Tissue and Implant Re-
pository; and specimens from asymptomatic controls were
obtained from the Repository of Joint Tissues from the Gift of Hope
Tissue and Organ Donor Network.Meniscal tear patients
Patients 18 years and older scheduled for arthroscopic knee
procedures were recruited to participate in the Knee Injury and
Arthritis repository. Patients undergoing ligament procedures were
excluded. The Institutional Review Board approved the study and
all patients gave written informed consent. For the current study
we chose patients with meniscal tears undergoing arthroscopic
partial meniscectomy. Synovial biopsies were collected from the
suprapatellar pouch during surgery and stored at 80C in RNA-
later (Life Technologies, CA) for gene expression analysis. Synovial
ﬂuids from these patients were obtained by needle arthrocentesis,
prior to establishment of the arthroscopic portals. Fluids werecentrifuged at 1000 g for 10 min to remove cells and debris, then
stored in aliquots at 80C prior to batch analysis.
Advanced OA patients and asymptomatic controls
For comparative evaluation of chemokine protein levels, bio-
specimens were also obtained from asymptomatic donors and from
patients with advanced OA. Synovial ﬂuid (SF) and tissue speci-
mens were obtained from patients with advanced OA undergoing
total knee replacement, who were participants in the Orthopedic
Tissue and Implant Repository at Rush University Medical Center.
All specimens from this repository came from patients with a
diagnosis of OA from the operating surgeon, and had clear radio-
graphic evidence of knee OA on pre-operative knee X-rays (Kell-
greneLawrence score > 2). Synovial tissue and ﬂuid was collected
and processed as described above. Synovial ﬂuids from asymp-
tomatic donors (based on no history of arthritis or chronic joint
pain) were obtained through the Repository of Joint Tissues from
the Gift of Hope Tissue and Organ Donor Network, maintained at
Rush University Medical Center. These de-identiﬁed biospecimens
were obtained within 24 h of death, and processed as described for
the meniscal tear and advanced OA patients.
Collection of clinical data
Clinical and demographic data for arthroscopy and arthroplasty
patients were obtained by chart review. Cartilage integrity was
assessed intra-operatively using the Outerbridge scale14, and
radiographic changes were scored on pre-operative X-rays using
the KellgreneLawrence (K-L) classiﬁcation15. For arthroscopy pa-
tients, the pattern of meniscal injury (degenerative vs traumatic)
was also evaluated intra-operatively by the surgeon where 0 ¼ no
tear,1¼ radial or longitudinal including bucket handle tear, 2¼ ﬂap
or oblique tear, 3 ¼ horizontal tear (likely degenerative),
4 ¼ complex tear with multiple cleavage planes (degenerative) and
5 ¼ complete maceration or destruction. In asymptomatic organ
donors, no X-rays were available but a pathologist assessed gross
degenerative joint changes at the time of dissection using the
modiﬁed Collins grading system16.
Knee symptom assessment
In the meniscal tear patients only, the Knee Injury and Osteo-
arthritis Outcome Score (KOOS), English version LK1.017 was used to
measure preoperative knee symptoms. Questionnaires, scoring
manual and user's guide were obtained from http://www.koos.nu.
The KOOS measures symptoms and disability on ﬁve separately
scored sub scales: Pain, other Symptoms, Activities of Daily Living
(ADL), Sports and Recreation and Quality of Life (QOL). Patients
completed the KOOS during routine pre-surgical clinical evalua-
tions, and questionnaires were obtained by chart review after
enrollment into the repository.
Gene expression analysis
Prior to evaluating inﬂammatory chemokine gene expression,
the presence of synovial inﬂammation in the meniscectomy pa-
tients was conﬁrmed in hematoxylin and eosin (H&E) stained thin
sections from a subset of 19 repository patients. Using a previously
reported grading system12,18, synovitis (grade 1 or above) was
conﬁrmed in 55% (n ¼ 11), similar to our previous report in a
separate group of meniscal arthroscopy patients12.
Total RNA was then extracted as described12 from synovial bi-
opsies available from a separate set of 19 meniscal tear patients, as
well as 16 advanced OA patients. RNA integrity was conﬁrmed on a
microﬂuidics-based system (Agilent Bioanalyzer, Agilent
Table I
Characteristics of patients with meniscal tears, and patients with advanced OA
included in the gene expression analysis
Meniscal tear
patients N ¼ 19
Advanced OA
patients N ¼ 16
P-value
Age, median (IQR), years 49 (42.2e55.5) 64 (58e72) 0.0002*
BMI, median (IQR), kg/m2 27.9 (23.7e31.8) 37.5 (23.3e42.8) 0.0004*
Male/Female N, (%) 14/5 (74/26) 6/10 (37.5/62.5) 0.04y
KellgreneLawrence Score,
median (IQR)
2 (1e2) 4 (4e4) <0.0001z
Outerbridge Score
(N, % of patients)
Grade 0 1 (5) 0 (0)
Grade 1 3 (15) 0 (0) 0.0019z
Grade 2 5 (25) 0 (0)
Grade 3 7 (35) 2 (12.5)
Grade 4 4 (20) 14 (87.5)
IQR ¼ Interquartile Range.
* Unpaired t-test.
y Fisher's Exact test.
z Fisher's Exact test, K-L 0e2 vs 3e4, or Outerbridge 0e2 vs 3e4.
A. Nair et al. / Osteoarthritis and Cartilage 23 (2015) 1158e11641160Technologies, Santa Clara, CA). All RNA was DNase treated, and
cDNA synthesized using the iScript cDNA Synthesis kit (Bio-Rad,
Hercules, CA). Expression levels of four chemokines and one che-
mokine receptor (CCL19, IL-8, XCL1, CCL5 and CCR7) identiﬁed in a
previous study12 was measured by real-time quantitative PCR using
speciﬁc primers and iQ SYBR Green Supermix (Bio-Rad, Hercules,
CA). After normalizing Ct values to GAPDH, expression levels in
meniscal tear patients were calculated relative to the mean of the
advanced OA group19,20.
Synovial ﬂuid (SF) CCL19 measurement
SF CCL19 was measured by ELISA (R&D Systems, Minneapolis,
MN) in a set of specimens from 10meniscal arthroscopy patients,10
advanced OA patients, and 10 asymptomatic donors. The lower
limit of detection for CCL19 was 15.6 pg/mL, and the ELISA was
performed according to the manufacturer's instructions using
freshly thawed aliquots of SF in duplicate.
Statistical analysis
SPSS version 19.0 and GraphPad Prism 5.0 were used for sta-
tistical analyses. Between group differences were evaluated using
KruskaleWallis and results conﬁrmed by Dunn's post-hoc tests to
compare individual groups. For categorical variables we used Fisher
exact or Chi-square tests, and unpaired t-tests or ManneWhitney U
tests for continuous variables. KOOS Pain, ADL and QOL surveys
were incomplete for one patient each, and questionnaires were
missing for two patients. To calculate KOOS subscores when there
were incomplete responses to the questionnaires, missing values
were calculated according to the KOOS scoring guide (available
from http://www.koos.nu/). Hot deck imputation methods21 were
then used to calculate scores for the twomissing questionnaires. To
determine whether chemokine levels correlated with KOOS sub-
scores in the meniscal tear patients, Pearson's correlations were
examined. Signiﬁcant correlations were then further tested using
hierarchical linear regression22 in order to determine whether re-
lationships between KOOS subscores (dependent variables) and
mRNA levels of chemokines (independent variables) remained
signiﬁcant after adjusting for other variables. In this hierarchical
approach, demographic variables (age, gender, BMI), Outerbridge
scores and KellgreneLawrence grades were entered into the
regression ﬁrst, followed by chemokine level. It was assumed that
the residuals of the regression were normally distributed, and this
was conﬁrmed by residual analysis of the ﬁnal regressionmodel. All
tests were conducted using a 2-tailed alpha of 0.05.
Results
Chemokine mRNA levels in meniscal and advanced OA patients
19 meniscal tear patients and 16 advanced OA patients had sy-
novial biopsies available for gene expression analysis. Synovial
tissues from asymptomatic donors were obtained up to 24 h post-
mortem, and were not included in this analysis as RNA was not
consistently of sufﬁcient quality to provide reliable results. The
characteristics of the patients included in this analysis are pre-
sented in Table I. Meniscal patients were signiﬁcantly younger than
advanced OA patients (P ¼ 0.0002). Median BMI was in the over-
weight range for meniscal patients and obese range in advanced OA
patients (P ¼ 0.0004). Gender distributions were statistically
different between the two groups (Fisher's exact P ¼ 0.04). Median
radiographic OA severity (K-L grades) differed signiﬁcantly be-
tween meniscal tear and advanced OA patients as expected
(P < 0.0001). All but two of the advanced OA patients hadOuterbridge grade 4 cartilage damage (exposed subchondral bone).
Two of 19 (10%) of meniscal patients had normal (K-L ¼ 0) X-rays,
and only one patient (5%) had normal appearing cartilage surfaces
assessed by the Outerbridge score; the majority exhibited grade 2
(n ¼ 5) and grade 3 (n ¼ 7) lesions. Meniscal scores indicated that
18 of 19 patients exhibited degenerative-type tears and one patient
had a radial tear. The predominance of degenerative-type tears and
cartilage integrity loss in the majority of these patients is indicative
of early to intermediate-stage knee OA. Meniscal scores were not
obtained for advanced OA patients.
CCL19, IL-8, CCL5, XCL1 and CCR7 were detected in all 19
meniscal tear patients and >90% of advanced OA patients (Fig. 1).
Relative expression (RE) of IL-8 and CCR7 was signiﬁcantly higher
in advanced OA patients ([Mean RE, þ/ SD] IL-8 ¼ 1.416, þ/
0.913, <0.001; CCR7 ¼ 1.659, þ/ 2.209, P ¼ 0.004) vs the meniscal
group (IL-8 ¼ 0.219, þ/ 0.171; CCR7 ¼ 0.278, þ/ 0.134). RE levels
of CCL19, CCL5 and XCL1 were similar in the two patient groups.
Relationship between chemokine levels and knee symptoms/
dysfunction in patients undergoing meniscal arthroscopy
In the meniscal patients, CCL19 mRNA RE was associated with
KOOS ADL (Pearson r ¼ 0.620, P ¼ 0.005), KOOS Pain (r ¼ 0.547,
P¼ 0.015), and KOOS QOL scores (r¼0.479, 0.038), indicating that
higher expression levels are associated with worse KOOS scores. No
signiﬁcant correlations between CCR7, CCL5, or IL-8 and KOOS
subscores were observed (data not shown).
Linear regression analysis revealed that CCL19 RE levels were
associated with KOOS ADL scores (estimate (B) ¼ 0.602, 95% CI
[8.071, 0.331], P ¼ 0.036) and were independent of age, gender,
BMI, degree of cartilage damage (Outerbridge Score) and radio-
graphic OA severity (K-L Score) in meniscal patients. Our ﬁnal
regression model including CCL19 RE levels explained 50% of the
variance in KOOS ADL scores (F ¼ 1.988, R2 ¼ 0.500, P ¼ 0.145)
[Table II(A)]. Regression analysis using Pain and QOL scores did not
demonstrate statistically signiﬁcant associations with CCL19
expression, after adjusting for covariates (KOOS Pain (B) ¼ 0.536,
P¼ 0.065; KOOS QOL (B)¼0.610, P¼ 0.070) [Table II(B) and II(C)].
Synovial ﬂuid CCL19 levels
To determine whether CCL19 protein is produced within the
joint, CCL19 levels in SF specimens from a separate set of 10
meniscal tear patients, 10 advanced OA patients, and 10
Fig. 1. Synovial mRNA RE levels in patients with meniscal tears and advanced OA. mRNA expression levels of CCL-19, CCR7, IL-8, XCL-1 and CCL5 were measured using Real-Time
PCR as described in Materials and Methods. Expression was calculated relative to the mean in the advanced OA group after normalizing to GAPDH. **P ¼ 0.004, ***P < 0.001.
Table IIA
Regression models to determine associations between KOOS ADL scores and CCL19
RE levels
Variable Estimate (SE) 95% CI P-value
Age 0.431 (0.621) 0.921, 1.783 0.501
Gender 28.927 (21.416) 75.588, 17.735 0.202
BMI 2.178 (1.77) 6.051, 1.694 0.244
Outerbridge Score 0.854 (5.699) 11.564, 13.271 0.883
K/L score 10.037 (9.529) 10.725, 30.799 0.313
CCL19 4.201 (1.776) 8.071, 0.331 0.036*
R2 0.500
F for R2 change 1.998
P-value for F 0.145
*P < 0.05.
Table IIB
Regression models to determine associations between KOOS Pain scores and CCL19
RE levels
Variable Estimate (SE) 95% CI P-value
Age 0.624 (0.560) 0.597, 1.845 0.288
Gender 23.097 (19.343) 65.241, 19.048 0.256
BMI 1.977 (1.605) 5.474, 1.521 0.242
Outerbridge Score 0.457 (5.147) 11.673, 10.758 0.931
K/L score 8.941 (8.607) 9.811, 27.693 0.319
CCL19 3.252 (1.604) 6.748, 0.243 0.065
R2 0.461
F for R2 change 1.771
P-value for F 0.202
Table IIC
Regression models to determine associations between KOOS QOL scores and CCL19
RE levels
Variable Estimate (SE) 95% CI P-value
Age 0.030 (0.652) 1.451, 1.391 0.965
Gender 0.276 (22.509) 49.319, 48.768 0.990
BMI 0.029 (1.868) 4.041, 4.099 0.988
Outerbridge Score 0.841(5.990) 13.893, 12.210 0.891
K/L score 6.935 (10.015) 14.887, 28.756 0.502
CCL-19 3.719 (1.867) 7.786, 0.349 0.070
R2 0.277
F for R2 change 0.766
P-value for F 0.610
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of synovial ﬂuid amounts in the repositories, this analysis only
included two of themeniscal patients and three of the advanced OA
patients included in the gene expression analysis. Characteristics of
the subset of patients and donors contributing SF are shown in
Table III. Arthroscopy and arthroplasty patients included in this
analysis were well matched for age, gender and BMI, although both
patient groups tended to be younger than the asymptomatic do-
nors. Again, K-L scores and Outerbridge scores were higher in the
advanced OA patients compared to the meniscal tear patients, as
expected. The arthroscopy patients contributing SF to this analysis
were similar to those included in the gene expression analysis, as
there was a predominance of degenerative-type tears and cartilage
integrity loss, indicating that the majority had early to
intermediate-stage knee OA.Table III
Characteristics of patients with meniscal tears, advanced OA, and asymptomatic
donors that contributed SF for CCL19 analysis
Meniscal tear
patients
N ¼ 9
Advanced OA
patients
N ¼ 10
Asymptomatic
donors N ¼ 10
P-value
Age, median
(IQR), years
53.5
(38.7e60.25)
55.5
(46.7e59.2)
69.5
(63.2e73.5)
0.004*
BMI, median
(IQR), kg/m2
34.4
(27.2e37.4)
37.6
(34.7e42.2)
N/A 0.08y
Male/Female
N, (%)
5/5 (50/50) 6/4 (60/40) 6/4
(60/40)
0.87z
KellgreneLawrence
Score, median (IQR)
2 (1e2.7) 4 (3e4) ND 0.007x
Outerbridge Score
(N, % of patients)
Grade 0 1 (11) 0 (0)
Grade 1 1 (11) 0 (0) ND 0.032x
Grade 2 2 (22) 0 (0)
Grade 3 2 (22) 2 (20)
Grade 4 3 (33) 8 (80)
SF CCL19 pg/ml
Median (IQR)
62.5
(0e117.9)
67.8 (0e200) 0 (0e59.3) 0.25k
N/A: Not available.
ND: Not done.
* One-way ANOVA followed by Holm-Sidak's multiple comparison test. Meniscal
vs asymptomatic, P ¼ 0.004; Advanced OA vs asymptomatic, P ¼ 0.02.
y Unpaired t-test.
z c2 test.
x Fisher's Exact test, K-L 0e2 vs 3e4, or Outerbridge 0e2 vs 3e4.
k KruskaleWallis.
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7/10 advanced OA patients, and 4/10 asymptomatic donors (c2,
P ¼ 0.28). Median (interquartile range) levels in meniscal tear pa-
tients were 62.5 (0e117.9), in advanced OA 67.8 (0e200), and in the
asymptomatic donors 0 (0e59.2) (Table III; KruskaleWallis
P ¼ 0.25).
Discussion
We previously reported a relationship between chemokine
markers of synovitis, and increased knee symptoms and dysfunc-
tion in patients undergoing arthroscopic meniscectomy without
radiographic evidence of OA12. In the current study, we sought to
determine whether this relationship between chemokine expres-
sion and knee symptoms could be replicated in a more typical
population of patients indicated for meniscal arthroscopy. The
majority of arthroscopy patients in this study demonstrated Out-
erbridge grade 1e4 cartilage lesions, had K-L radiographic scores
>/ ¼ 2, consistent with published reports demonstrating pre-
radiographic or radiographic evidence of OA in many patients
presenting with symptomatic meniscal tears14,15. This is in contrast
to the select group in our previous pilot study, 20% of whom had no
cartilage abnormality, and all of whom had normal radiographs (K-
L grade 0). Therefore, the current study allowed us to validate our
previous ﬁndings with the goal of identifying markers of inﬂam-
mation in a more heterogeneous but representative clinical
population.
We focused our analysis on four inﬂammatory chemokines and
one receptor identiﬁed previously: CCL19, IL-8, CCL5, XCL-1 and
CCR7. These genes are involved in the recruitment and trafﬁcking of
leukocytes, including monocytes, lymphocytes, dendritic cells,
neutrophils, and eosinophils to sites of inﬂammation23. All ﬁve
transcripts were expressed by the majority of patients presenting
for meniscal surgeries and patients with advanced OA (Fig. 1).
Levels of CCR7 and IL-8 transcripts were signiﬁcantly higher in the
advanced OA group, while levels of CCL19, XCL1, and CCL5 were
similar in the two groups. Expression of various chemotactic factors
has been previously reported in knee injury and OA patients. A
previous study by Cuellar et al.24 showed increased mean synovial
ﬂuid concentrations of monocyte chemotactic protein-1 (MCP-1)
and macrophage inﬂammatory protein-1 (MIP-1b) in patients with
acute symptomatic meniscal injury compared with asymptomatic
control subjects. Another recent study detected CCL5 protein levels
in synovial ﬂuid, but reported lower levels in post-traumatic
arthroscopy patients compared to OA patients undergoing total
knee replacements25. Elevated gene expression levels of proin-
ﬂammatory cytokines and chemokines in the meniscus have also
been reported in young patients with an isolated meniscal tear26
suggesting the meniscus itself may be a source of these media-
tors. These studies alongwith our observations give further support
to the hypothesis that low-grade inﬂammation is a characteristic of
OA disease even in early stages. In contrast to other studies, our
analysis focused solely on chemotactic factors speciﬁcally identiﬁed
based on their association with histologic synovitis12.
Next we investigated whether these markers of synovitis were
associated with pre-operative symptoms measured using the KOOS
outcome score. We found that of the ﬁve mediators measured, only
synovial CCL19 mRNA expression levels were associated with KOOS
scores. Unadjusted associations were observed with KOOS-ADL,
KOOS-Pain, and KOOS e QOL subscores, but the association with
KOOS-ADL was independent of age, gender, BMI, K-L and Outer-
bridge scores. As we had limited numbers of synovial tissues from
arthroscopy patients with a full set of clinical data in the repository,
we used an exploratory analytic approach without adjustment for
multiple tests of hypotheses. We chose this approach to balanceconcerns of obtaining a spurious relationship against the danger of
making a Type II error (accepting the null hypothesis when it is
false). Despite its limitations, this approach replicated, strength-
ened and expanded our previous ﬁndings12, and demonstrated that
CCL19 mRNA expression in the synovium is associated with more
severe symptoms in more typical meniscal arthroscopy patients,
despite numerous potential confounding factors such as BMI, and
varying degrees of pre-existing OA. Although a cause and effect
relationship between the activity of CCL19 and knee-related
dysfunction cannot be extrapolated from this study, this associa-
tion is intriguing, and should be explored in future mechanistic
studies. Of note, gene expression levels of CCL19 along with other
OA related genes have been shown to be up-regulated in post-
traumatic mouse models of OA, suggestive of the importance of
these genes in an early inﬂammatory response to joint injury and
progression of OA27,28.
The use of the KOOS instrument in this study allowed us to
further deﬁne the relationship between CCL19 mRNA expression
and speciﬁc knee-related symptoms. The Lysholm score used pre-
viously is a clinician-administered survey, which measures pain,
other symptoms and knee-related dysfunction in a variety of tasks
on a single scale, and therefore cannot discriminate between spe-
ciﬁc domains of symptoms and functioning. In contrast, the KOOS is
a patient-administered knee instrument which measures pain,
other symptoms, function and QOL on ﬁve independent subscales17
and has been validated in knee injury populations including pa-
tients undergoing meniscal arthroscopies29. Using the KOOS, we
identiﬁed an independent associationwith the KOOS ADL subscore,
which measures knee-related difﬁculty/dysfunction with ADL. Our
results are consistent with those of Sowers et al., who found an
association between MRI-deﬁned synovitis and knee-related
dysfunction in OA patients, using objective measurement of stair-
climbing and walking times30. The speciﬁc reasons for a relation-
ship between levels of this inﬂammatory mediator and knee
dysfunction are as yet unclear, but we speculate may be related to
inﬂammation-associated symptoms such as stiffness. Further
studies using animal models are necessary to understand whether
a mechanistic link between CCL19 and knee-related symptoms and
dysfunction in early stages of OA, exists.
mRNA expression levels of CCL19 were similar in the advanced
knee OA and meniscal patients, most of whom had signs of early
stage OA either on X-ray or intra-operatively. Our SF ELISA mea-
surement conﬁrmed that CCL19 is indeed expressed at the protein
level in the joint. CCL19 was detectable in 7 of 10 SF from meniscal
arthroscopy patients, and median levels were 62.5 (0e117.9). SF
CCL19 was also detectable in 7 of 10 patients with advanced knee
OA and median levels were similar (Table III). In contrast, CCL19
was detectable in SF from 4 of 10 asymptomatic donors, and me-
dian levels were 0 (0e59.2) (Table III; KruskaleWallis P ¼ 0.25).
Although not statistically signiﬁcant given the small numbers of
samples, this comparative analysis indicates that levels may be
higher in disease compared to asymptomatic donors. However, we
cannot rule-out variable post-mortem degradation of the donor
specimens which is a limitation of this comparison.
Additional limitations of this study include small numbers as
well as the cross-sectional nature of the design. Longitudinal
studies are needed to determine a relationship between expression
of these chemokines with post-operative prognosis, and to further
elucidate longitudinal changes in gene expression patterns. Prob-
lems with using regression analyses are well known31, including
the possibility of ﬁnding a signiﬁcant result that is instead an
artifact of co-linearity among variables. We attempted to minimize
this chance by using a hierarchical approach to entry of variables
based on theoretical importance22. Although causation cannot be
inferred by this approach alone, it can be used to develop possible
A. Nair et al. / Osteoarthritis and Cartilage 23 (2015) 1158e1164 1163associations between interrelated variables such as the ones
examined in the current analysis32. As the regression models used
in this report were exploratory in nature, validation of these
markers in larger populations is needed, as well as in other joint
injury and at-risk patients to determine if CCL19 has value in pre-
dicting outcomes including risk of OA. Even with these limitations,
we were able to validate the relationship between synovial CCL19
mRNA expression and knee symptoms/dysfunction that we previ-
ously identiﬁed, and demonstrate that CCL19 protein was detect-
able in a more heterogeneous but representative clinical
population. Our study provides support that synovial CCL19
expression may be a signature chemokine marker associated with
inﬂammatory inﬁltration and knee-related dysfunction in the
setting of meniscal degeneration and early stage knee OA.
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